Russia introduces in the CIS a remuneration system for drug and reimbursement systems decided recently Ukraine, for medicines, as it already practiced in other countries will introduce. These reporting systems are actually introduced, this change could complete new design the framework for generic and innovative medicines. Ukraine: Hypertension drugs project In 2012 Ukraine started a project that introducing approved of government regulation of the rates of high blood pressure medicines, as also the partial reimbursement of expenses has allows loads of State and municipal budgets. According to Ministry of health data about 12 million people suffer high blood pressure in the Ukraine. Pharmacy chains have reduced the rates of registered, generic drugs from August 1, 2012 in the Ukraine. In November 2012, the partial reimbursement of expenses for the patients is introduced drugs for high blood pressure.
This possibility was at the beginning of the year 2013 to December 2013 extended. 2013, Approximately 18.7 million was approved by the Government the project budget for the reimbursement of expenses for the year. This would correspond approximately 600 million defined daily dose of blood pressure lowering medications to, 66 million more than the year 2012. Russia: Strategy for a refund system by 2025 In February 2012 has unveiled the “strategy for the supply of the Russian population with medicines for the period up to the year 2025” Russian Minister for health. The main objective is to increase the availability of high-quality, effective and safe medicines.
The strategy focuses on areas such as increasing the availability of medicines, the support the use of Russian products or increasing the scope of preventive measures in the medical. Currently come in Russia only for some groups of the population to enjoy of the drug reimbursement, such as veterans, invalids and children up to 3 years. This is extended to several categories of citizens be. The implementation of the strategy will be financed from the federal budget, the budgets of regional and local entities and extrabudgetary sources. There are plans to implement an effective drug supply model, between 2017 and 2025 during the third phase of the programme. The strategy has five key objectives: the rational use of medicines improvement of the procedure for establishing the list of drugs ensuring the safety, efficacy and quality of drugs improving State regulation of prices of medicines training of medical and pharmaceutical staff